Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bruker (BRKRP) EBITDA (2016 - 2025)

Bruker's EBITDA history spans 16 years, with the latest figure at $12.7 million for Q4 2025.

  • For Q4 2025, EBITDA fell 82.39% year-over-year to $12.7 million; the TTM value through Dec 2025 reached $4.6 million, down 98.18%, while the annual FY2025 figure was $4.6 million, 98.18% down from the prior year.
  • EBITDA reached $12.7 million in Q4 2025 per BRKRP's latest filing, up from -$51.8 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $131.0 million in Q4 2022 to a low of -$51.8 million in Q3 2025.
  • Average EBITDA over 5 years is $54.0 million, with a median of $55.8 million recorded in 2022.
  • Peak YoY movement for EBITDA: skyrocketed 227.56% in 2021, then crashed 176.06% in 2025.
  • A 5-year view of EBITDA shows it stood at $80.6 million in 2021, then soared by 62.53% to $131.0 million in 2022, then dropped by 20.99% to $103.5 million in 2023, then tumbled by 30.34% to $72.1 million in 2024, then tumbled by 82.39% to $12.7 million in 2025.
  • Per Business Quant, the three most recent readings for BRKRP's EBITDA are $12.7 million (Q4 2025), -$51.8 million (Q3 2025), and $11.9 million (Q2 2025).